O
OrbiMed’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-764,600
| Closed | -$11.8M | – | 112 |
|
|
2024
Q3 | $11.8M | Buy |
+764,600
| New | +$11.8M | 0.21% | 76 |
|
|
2021
Q1 | – | Sell |
-265,772
| Closed | -$14.2M | – | 154 |
|
|
2020
Q4 | $14.2M | Buy |
265,772
+158,772
| +148% | +$8.49M | 0.12% | 115 |
|
|
2020
Q3 | $4.41M | Buy |
+107,000
| New | +$4.41M | 0.06% | 127 |
|
|
2020
Q1 | – | Sell |
-96,143
| Closed | -$4.11M | – | 140 |
|
|
2019
Q4 | $4.11M | Hold |
96,143
| – | – | 0.06% | 105 |
|
|
2019
Q3 | $3.46M | Sell |
96,143
-5,757
| -6% | -$207K | 0.07% | 96 |
|
|
2019
Q2 | $2.72M | Buy |
+101,900
| New | +$2.72M | 0.04% | 111 |
|
|
2018
Q3 | – | Sell |
-4,282,400
| Closed | -$65.4M | – | 147 |
|
|
2018
Q2 | $65.4M | Buy |
4,282,400
+941,700
| +28% | +$14.4M | 0.78% | 42 |
|
|
2018
Q1 | $75.1M | Buy |
3,340,700
+2,491,600
| +293% | +$56M | 0.93% | 37 |
|
|
2017
Q4 | $25.6M | Buy |
+849,100
| New | +$25.6M | 0.32% | 71 |
|
|
2017
Q2 | – | Sell |
-1,169,000
| Closed | -$40.2M | – | 135 |
|
|
2017
Q1 | $40.2M | Buy |
+1,169,000
| New | +$40.2M | 0.46% | 57 |
|
|
2016
Q2 | – | Sell |
-1,401,600
| Closed | -$39.2M | – | 133 |
|
|
2016
Q1 | $39.2M | Buy |
+1,401,600
| New | +$39.2M | 0.41% | 55 |
|
|
2014
Q1 | – | Sell |
-135,000
| Closed | -$3.37M | – | 120 |
|
|
2013
Q4 | $3.37M | Sell |
135,000
-177,000
| -57% | -$4.42M | 0.05% | 99 |
|
|
2013
Q3 | $8.57M | Sell |
312,000
-981,000
| -76% | -$26.9M | 0.15% | 74 |
|
|
2013
Q2 | $23.5M | Buy |
+1,293,000
| New | +$23.5M | 0.5% | 38 |
|